Literature DB >> 15526816

The response to beta-agonists in wheezy infants: three methods compared.

Caroline S Beardsmore1, Catherine Page, Michael Silverman.   

Abstract

BACKGROUND: Studies into the effects of salbutamol in the treatment of wheeze in infancy have been conflicting, possibly due to differences in outcome variables. We aimed to assess the response to salbutamol using indices derived from passive and forced expiration.
METHODS: We recruited 39 infants who had a history of wheezing (mean age 43 weeks) and measured maximum flow at functional residual capacity (V'(max FRC)) by rapid thoracoabdominal compression (RTC), and forced expired volume at 0.4s (FEV0.4) using the raised-volume RTC technique (RV-RTC). We calculated passive compliance (C(rs)), resistance (R(rs)) and time constant (tau) from relaxed expirations that followed the augmented inspirations delivered during RV-RTC. Measurements were repeated after aerosol salbutamol (800 mcg).
RESULTS: Data were obtained in 32 infants for V'(max FRC), 22 for FEV0.4 and 19 for passive mechanics. There were no mean changes in any index of forced expiration after salbutamol. Some individuals showed significant changes (improvement or worsening) in one or other index. Overall, there was a small increase in C(rs) after salbutamol but no change in R(rs) or tau.
CONCLUSIONS: We found no consistent pattern of response in either index of forced expiration. Validated clinical scores or alternative physiological techniques may be preferable to respiratory mechanics in assessing bronchodilator response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526816     DOI: 10.1016/j.rmed.2003.12.019

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors.

Authors:  Jason Debley; Sanja Stanojevic; Amy G Filbrun; Padmaja Subbarao
Journal:  Pediatr Pulmonol       Date:  2011-10-17

Review 2.  Beta2-agonists for asthma: the pediatric perspective.

Authors:  Padmaja Subbarao; Felix Ratjen
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

3.  Nasal versus oronasal raised volume forced expirations in infants--a real physiologic challenge.

Authors:  Mohy G Morris
Journal:  Pediatr Pulmonol       Date:  2012-02-10

4.  Comprehensive integrated spirometry using raised volume passive and forced expirations and multiple-breath nitrogen washout in infants.

Authors:  Mohy G Morris
Journal:  Respir Physiol Neurobiol       Date:  2009-11-06       Impact factor: 1.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.